Evotec expands compound management capability to US East Coast

Published: 29-Apr-2013
Manufacturing

Will open a new plant in Branford, Connecticut in the third quarter


Evotec (US) has signed a multi-year lease on a plant specifically designed to expand the company’s compound management services on the East Coast of the US.

The facility, located in Branford, Connecticut, will support Evotec’s drug discovery collaborators along the East Coast. The company said it would be ‘scalable for continued growth’.

The facility will be fully operational early in the third quarter and will complement Evotec’s existing facility in South San Francisco, which will continue to be fully operational.

Scott Snyder, Executive Vice President Compound Management of Evotec, said: ‘This is an important strategic expansion of our EVT Execute compound management offering which Evotec first acquired in South San Francisco in 2011. The significant investment will enable Evotec to compete better for East Coast compound management opportunities.’

No financial details have been revealed.

  • Companies:
  • Evotec
See more

You may also like

Manufacturing

Evotec strikes up a deal with Monacum Partners to sell its Halle API manufacturing facility

Read more
The CDMO faction of Evotec will now function as DAPIN GmbH, which will continue to specialise in end-to-end chemical API development and manufacturing

Trending Articles

  1. Fujifilm Diosynth Biotechnologies expands its biologic manufacturing capabilities at Hillerød site The CDMO's first expansion phase introduces six more 20,000 L bioreactors and two downstream processing streams to the facility
  2. Olon commits to ultra-potent compound manufacturing expansion with new €25m facility The CDMO's integrated small and large-scale lines can produce payloads, linker payloads and ultra-potent APIs for customers across Europe
  3. Small batch, big impact Stephen Hayes, Managing Director at Beckhoff Automation, explores the benefits of embracing flexible manufacturing for personalised medicine
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles
  5. Lonza's Synaffix and BigHat Biosciences team up to develop ADC pipeline programme Synaffix's clinical-stage ADC platform technology will allow BigHat to expand and progress its ADC pipeline for oncological indications

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Evotec strikes up a deal with Monacum Partners to sell its Halle API manufacturing facility

The CDMO faction of Evotec will now function as DAPIN GmbH, which will continue to specialise in end-to-end chemical API development and manufacturing
Manufacturing

Titian and Evotec sign three-year agreement for sample management platform

The two companies have entered into an agreement that means Titian's software user licences can enable rapid deployment across new Evotec stites
Manufacturing

Romaco showcases its solid dosage processing portfolio at CPHI & PMEC India

The company will display its portfolio suitable for the granulation, tableting, and coating of pharmaceutical solids
Manufacturing

Ensuring sterility and precision in pharma

Specialty bearings for efficiency in pharmaceutical production
Manufacturing

Overcoming mixing challenges in medical technology applications

The medical device and pharmaceutical markets rely on the fast and homogenous mixing of materials for many applications, such as during drug development and delivery or when creating medical implants
Manufacturing

Fujifilm Diosynth Biotechnologies expands its biologic manufacturing capabilities at Hillerød site

The CDMO's first expansion phase introduces six more 20,000 L bioreactors and two downstream processing streams to the facility
Manufacturing

Small batch, big impact

Stephen Hayes, Managing Director at Beckhoff Automation, explores the benefits of embracing flexible manufacturing for personalised medicine
Subscribe now